Page last updated: 2024-09-05

tak 779 and Adenocarcinoma

tak 779 has been researched along with Adenocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kadam, PA; Lawrence, DM; Peehl, DM; Vaday, GG	1

Other Studies

1 other study(ies) available for tak 779 and Adenocarcinoma

Article	Year
Expression of CCL5 (RANTES) and CCR5 in prostate cancer. The Prostate, 2006, Feb-01, Volume: 66, Issue:2 Topics: Adenocarcinoma; Amides; Autocrine Communication; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Chemokine CCL5; Chemokines, CC; Disease Progression; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Neoplasm Invasiveness; Prostatic Neoplasms; Quaternary Ammonium Compounds; Receptors, CCR5; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger	2006

Article

Year

Expression of CCL5 (RANTES) and CCR5 in prostate cancer.

The Prostate, 2006, Feb-01, Volume: 66, Issue:2

Topics: Adenocarcinoma; Amides; Autocrine Communication; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Chemokine CCL5; Chemokines, CC; Disease Progression; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Neoplasm Invasiveness; Prostatic Neoplasms; Quaternary Ammonium Compounds; Receptors, CCR5; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2006